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Abstract
Background/Objective:  There  is  increasing  evidence  that  positive  life  changes,  such  as  post-
traumatic  growth  (PTG),  can  result  from  the  experience  of coping  with  cancer.  However,  no
interventions  have  been  specifically  designed  to  facilitate  the  development  of  PTG  in  cancer.
In this  article,  we  describe  and  assess  the  results  of  Positive  Psychotherapy  for  Cancer  (PPC)
survivors. It  aims  to  facilitate  PTG  as  a  way  of  achieving  significant  reductions  in the  symp-
toms of  emotional  distress  and posttraumatic  stress.  In  addition,  the  corroboration  of  this  PTG
facilitation  is assessed  using  interpersonal  indicators.  Method:  We  allocated  126 consecutive
survivors of  cancer  with  high  levels  of  emotional  distress  and  who  were  seeking  psychological
support  to  either  an experimental  group  (PPC)  or  a  waiting  list  group.  Results:  The  PPC  group
obtained significantly  better  results  after  treatment  than  the  control  group,  showing  reduced
distress,  decreased  posttraumatic  symptoms,  and  increased  PTG.  The  benefits  were  maintained
at 3 and  12  months’  follow-up.  Participants’  PTG  was  correlated  to  the  PTG  that  their  signif-
icant others  attributed  to  them,  corroborating  PTG  facilitation.  Conclusions:  PPC  appears  to
promote significant  long-term  PTG  and can  reduce  emotional  distress  and  posttraumatic  stress
in cancer  survivors.  In  addition,  PTG  facilitation  induced  by  PPC  is corroborated  by  significant
others.
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Psicoterapia  Positiva  para  supervivientes  de  cáncer  con  elevados  niveles  de malestar
emocional:  la  facilitación  del crecimiento  postraumático  reduce  el  estrés
postraumático
Resumen
Antecedentes/Objetivo:  La  evidencia  científica  muestra  la  importante  presencia  de  cam-
bios vitales  positivos,  como  el  crecimiento  postraumático  (CPT),  tras  afrontar  un  cáncer.  Sin
embargo,  ninguna  intervención  ha  sido  específicamente  disen˜ada  para  facilitar  el  CPT  en
pacientes  con  cáncer.  En este  artículo,  se  describen  y  evalúan  los  resultados  de la  Psicoterapia
Positiva  dirigida  a  supervivientes  de  Cáncer  (PPC),  disen˜ada  para  facilitar  el CPT  como  vía  para
reducir  el malestar  emocional  y  estrés  postraumático.  Utilizamos  indicadores  interpersonales
para validar  la  autenticidad  del  CPT.  Método:  Ciento  veintiséis  supervivientes  de cáncer  con  ele-
vados niveles  de  malestar  emocional  fueron  consecutivamente  asignados  al  grupo  experimental
(PPC) o al  grupo  de lista  de espera.  Resultados:  El grupo  de PPC  obtuvo  significativamente
mejores resultados  después  del  tratamiento  que  el  grupo  control,  mostrando  una  reducción  del
malestar psicológico,  de  los  síntomas  de  estrés  postraumático  y  un  incremento  del CPT.  Los
beneficios  se  mantuvieron  a  los  3  y  12  meses.  El CPT  fue  corroborado  por  los  seres  queridos
de los  participantes.  Conclusiones:  La  PPC  parece  promover  de forma  significativa  el  CPT  y
reduce el  malestar  emocional  y  el  estrés  postraumático  en  supervivientes  de  cáncer.  Además,
la facilitación  de  CPT  inducido  por  la  PPC  es  corroborada  por  los seres  queridos.
© 2016  Asociacio´n  Espan˜ola  de Psicolog´ıa Conductual.  Publicado  por  Elsevier  Espan˜a,  S.L.U.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Severe  illnesses  like  cancer  are adverse  life  experiences
that  have  a  high  psychological  impact.  Many  investigations
have  explored  the negative  psychological  consequences  of
cancer,  which  include  fatigue,  distress,  depression,  and
posttraumatic  stress  (Haberkorn  et  al.,  2013; Sheppard,
Llanos,  Hurtado-de-Mendoza,  Tailor,  & Adams-Campbell,
2013). In  fact,  35%--38%  of patients  develop  distress  when
diagnosed  with  cancer  (Carlson,  Waller,  &  Mitchell,  2012).
There  is  also  a considerable  body  of  evidence  associating
this  distress  with  poorer  quality  of life, less  adherence  to
cancer  treatments,  and  worse  overall  survival,  as  well  as
poorer  self-care  and  a  less  healthy  lifestyle  (Antoni,  2012;
Spiegel,  2012).
In  addition  to  distress,  a cancer  diagnosis  can  trigger  pos-
itive  life  changes  in  survivors  (Ochoa,  Castejon,  Sumalla,  &
Blanco,  2013;  Sawyer,  Ayers,  &  Field,  2010;  Sumalla,  Ochoa,
&  Blanco,  2009).  These  positive  changes  have  been  concep-
tualized  as  posttraumatic  growth  (PTG)  in  the literature.
PTG  refers  to  positive  cognitive  and behavioral  changes  after
adversity  and  trauma.  According  to the  influential  model
of  Tedeschi  and  Calhoun  (1996),  positive  changes  can  be
observed  in several  domains:  a) self-concept  (e.g.,  new
valuation  of  one’s  own  strength  and  resilience);  b)  apprecia-
tion  of  new  possibilities  in life;  c) social  relationships  (e.g.,
feeling  emotionally  closer  to  others,  especially  family  and
friends);  d)  life  philosophies  (e.g.,  reordering  of values  and
priorities);  and  e)  spiritually  (e.g.,  increased  participation
in  religious  activities).
The  results  of  meta-analyses  show  that  those  patients
with  cancer  who  experience  PTG tend  to  adapt  to  their  ill-
ness  more  successfully,  reporting  better  subjective  physical
and  mental  health,  lower  symptoms  of distress  and  post-
traumatic  stress,  as  well  as  healthier  behaviors  and  higher
adherence  to  oncological  treatments  (Helgeson,  Reynolds,
&  Tomich,  2006;  Sawyer  et  al.,  2010).
Traditionally,  the  focus  of  psychotherapy  in cancer  has
been  on stress  reduction  and  on  restoring  the  emotional
state  prior  to  illness.  However,  over the last  two  decades,
psychology  has  placed  greater  emphasis  on  the positive
aspects  of human  functioning,  such as  positive  emotions,
personal  meanings,  growth  and  strengths,  which has  led
to the proposal  of  a  number  of  successful  positive  psy-
chology  interventions  in cancer  to  enhance  quality  of life
and  reduce  distress  (Casellas-Grau,  Font,  & Vives,  2014). A
recent  meta-analysis  showed  that  those  psychological  treat-
ments,  which  tend  to  reduce  the  most  cancer  participants’
depressive  symptoms  were,  in  turn,  the  ones  which resulted
in  greater  benefits  on  their  quality  of  life  (De la  Torre-Luque,
Gambara,  López,  &  Cruzado,  2016).  Moreover,  positive  psy-
chology  interventions  showed their  important  effects  in
increasing  affect (Woodworth,  O’Brien-Malone,  Diamond,  &
Schüz, 2016).
In  this  study,  we  applied  a program  of Positive  Psy-
chotherapy  for Cancer  (PPC)  survivors  that  was  developed
through  extensive  research  and  a review  of  the literature  on
trauma  and  PTG  (Ochoa  et al.,  2013;  Sumalla  et  al.,  2009;
Vázquez,  Pérez-Sales,  &  Ochoa,  2014). The  basic  aim  of  PPC
is  to  facilitate  PTG  in cancer  survivors,  and it was  designed
to  complement  and  enhance  traditional  psychological  treat-
ments,  such  as  stress  management  (Antoni,  2003).  There-
fore,  PPC  focuses  closely on  a  patient’s  positive  resources,
such as positive  emotions,  strengths,  and  personal  mean-
ings  (Ochoa  et al.,  2010;  Rashid  &  Seligman,  2013)  because
its  assumption  is  that  individuals  have an inherent  desire  for
growth,  fulfillment,  and happiness,  rather  than  merely  seek-
ing  to  avoid  misery,  worry,  or  anxiety.  A substantial  portion  of
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suffering,  emotional  distress,  and psychopathology  in can-
cer  is  related  to the  enormous  and  urgent  need  to  make
positive  life  changes  (growth),  which  arises  after  the total
or  partial  awareness  of  their  mortality  (Ochoa  & Casellas-
Grau,  2015).  Then,  an important  part  of  a cancer  survivor’s
suffering  could  be  related  to  the frustration  of this  need
of  growth  after  the threat  to  life.  As  a  recent  meta-analysis
explores  (Roepke,  2014),  the facilitation  of  PTG  could  there-
fore  provide  an important  psychotherapeutic  framework
when  seeking  to  reduce  high  and  sustained  levels  of  distress
and  posttraumatic  stress  after  oncological  treatment.
In their  organismic  valuing  theory  of  adaptation  to
threatening  events,  Joseph  and  Linley  (2006)  explain  how
emotional  distress  and  PTG could  be  integrated  in the same
framework  of  human  experience.  They  distinguish  two  main
processes  in the  adaptation  to  threatening  events:  assimila-
tion  and  accommodation.  Assimilation  focuses  on  managing
the  stressful  event  and  trying  to  make  it consistent  with
their  basic  beliefs  to keep  them from  changing.  The  pres-
ence  of  severe  distress  or  posttraumatic  stress  points  to  the
need  for  elaboration  of the  traumatic  event that  is  caus-
ing  the  individual  to  question  their  vision  of  themselves,  the
world,  and  others.  The  maintenance  of  posttraumatic  stress
and  emotional  distress  can  be  broadly  used  as  indicators  of
a  difficult  or  dysfunctional  assimilation.  In  contrast,  accom-
modation  represents  the  changes  that  the person  makes  to
their  basic  beliefs  when seeking  to  incorporate  an intense
and  difficult  experience.  When  promoting  PTG,  we  are  facil-
itating  this  process  to  reduce  distress  and  posttraumatic
stress  in  response  to  the traumatic  information  trigger  (i.e.,
the  cancer  experience).
A  relevant  debate  for  therapies  focused  on  facilitating
PTG  concerns  the ‘‘real’’  or  ‘‘illusory’’  nature of  PTG in
cancer  (Sumalla  et  al.,  2009;  Widows,  Jacobsen,  Booth-
Jones,  & Fields,  2005).  The  models  that emphasize  the
illusory  nature  of  the  PTG processes  identify  assimilation  as
the  operative  mechanism  (Joseph  & Linley,  2006;  Sumalla
et  al.,  2009)  and question  the  presence  of  positive  iden-
tity  changes;  thus,  they  argue  that  PTG  is  merely  a coping
strategy.  It is  claimed  that  this strategy  or  ‘‘positive  illu-
sion’’  aims  to  counteract  or  protect  the individual  from
the  distress  caused  by  calling into  question  the coherence,
sense,  and  self-esteem  of  the subject’s  identity,  as  a  result
of  the  illness  (Taylor, Kemeny,  Reed,  Bower,  &  Gruenwald,
2000).  Two  interpersonal  indicators  have  been  used to  cor-
roborate  the  authenticity  of  PTG  that are based on  the
information  given  by  patients’  significant  others  regarding
the  cancer  patient’s  PTG (Ochoa  et  al.,  2013). One  indi-
cator  is  the  ‘‘relational’’  or  ‘‘vicarious’’  PTG  reported  by
significant  others  (usually  partners)  in themselves  after the
experience  of  their  loved  one’s  illness.  The  other  interper-
sonal  indicator  is  the  ‘‘transmitted’’  or  ‘‘corroborated’’  PTG
where  significant  others  report  whether  the cancer  survivor
has  demonstrated  PTG  (Moore  et  al.,  2011).  Thus,  if sig-
nificant  others  show vicarious  growth  or  can  corroborate
the  patient’s  growth,  the authenticity  of the  cancer  sur-
vivor’s  growth  is  improved  (Moore  et  al.,  2011;  Ochoa  et al.,
2013).
In view  of  these  considerations  and the lack  of  specific
data  in this  area,  we  aimed  to  evaluate  the  effects  of PPC
on  posttraumatic  stress  and distress  reduction  through  PTG
facilitation  among  cancer  survivors  compared  to  a  waiting
list  (control)  group.  The  study  also  assessed  the authenticity
of  PTG facilitation  by  PPC,  using  interpersonal  indicators.
Methods
Participants
One  hundred  and  fifty-eight  women  with  diverse  cancer
diagnoses  were  recruited  between  April  2008  and October
2013.  Participants  were  referred  by  medical  oncologists  or
nurses  to  the psycho-oncology  unit of a comprehensive  can-
cer  center  (the  Duran  i Reynals  Hospital)  if they  presented
emotional  distress  at the  end  of  their  primary  oncological
treatment.  Distress  thermometers  were  used and  patients
with  scores  ≥ 5 were  referred  to  the psycho-oncology  unit.
In  a southern  European  cancer  sample,  this  cut-off  point  was
found  to  be  appropriate  for  detecting  general  psychosocial
morbidity  (Gil,  Grassi,  Travado,  Tomamichel,  &  Gonzalez,
2005). Participants  meeting  the  following  inclusion  criteria
were  then  invited  to participate:  (a)  age  18--70  years  old;
(b)  presence  of  a  single  primary  cancer;  (c)  primary  onco-
logical  treatment  (surgery,  chemotherapy,  or  radiotherapy)
completed;  (d)  presence  of  significant  clinical  distress,  with
a  global  score  of 10  or  more  on  the HADS  (The  Hospital  Anxi-
ety  and  Depression  Scale);  and  (e)  ability  to understand  and
read  Spanish.  We  excluded  patients  if they  reported  any
prior  cancer,  any  prior  or  current  severe  mental  disorders
(hospitalization  or  formal  diagnosis  of  psychosis,  suicidality,
or  substance  dependence),  or  any  major  concurrent  medi-
cal  disease  seriously  affecting  their  cognitive  performance
(e.g.,  neurologic  disorders).  Participants  were  assessed  at
baseline  (T0),  immediately  after  PPC  treatment  (T1),  and
at 3 months  (T2)  and  12  months  (T3)  after  treatment.  The
study  was  carried  out  according  to the  latest  version  of  the
Declaration  of  Helsinki.  Approval  was  given  by  the ethics
committee  of our  hospital  and all  participants  gave  written
informed  consent.
Instruments
We used validated  questionnaires  to  assess  mood  (distress),
posttraumatic  stress,  PTG,  and  extreme  life  events.
Mood.  The  Hospital  Anxiety  and  Depression  Scale  (HADS)
measures  anxiety  and depression  in people  with  physical  ill-
ness  (Zigmond  &  Snaith,  1983), and  has  been  widely  used  to
assess  mood  in patients  with  cancer.  There  are  seven  items
for  both anxiety  and  depression,  with  total  scores  ranging
from  0  to  21.  Costa-Requena,  Pérez  Martin,  Salamero  Baro,
and  Gil  Moncayo  (2009)  validated  the  tool  in a  Spanish  sam-
ple of  oncology  outpatients,  with  their  results  showing  good
internal  reliability  for  each  subscale  (Cronbach’s  alphas  of
.82  and  .84  for  the anxiety  and  depression  subscales,  respec-
tively).  In  the  current  sample,  similar  Cronbach’s  alphas
were  obtained  (.79  for  the anxiety  scale  and  .84  for  the
depression  scale).
Posttraumatic  Stress.  The  Posttraumatic  Stress  Disor-
der  Checklist-Civilian  version  (PCL-C;  Weathers,  Litz,  Huska,
&  Keane,  1994) is  a 17-item  self-rating  questionnaire.  It
uses  a five-point  Likert  scale  ranging  from  1  (not  at all)
to  5  (extremely) that  covers  all  of the diagnostic  crite-
ria  for posttraumatic  stress  disorder  in the  Diagnostic  and
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Statistical  Manual  of  Mental  Disorders,  Fourth  Edition. The
questionnaire  yields  both  a total  score  and three  sub-
scale  scores  based  on  re-experiencing,  avoidance/numbing,
and  hyperarousal.  In the  current  sample,  PCL-C  obtained
proper  values  of  reliability  (.91  for  total  score,  .85 for
the  hyperarousal/re-experiencing  subscale,  .80  for num-
bing,  and  .72 for avoidance  subscale).  These  values  were
similar  to  the  Spanish  version  of  the PCL-C,  which  also  has
a  good  total  score reliability  of  .90, and coefficients  of  .87,
.78,  and  .69  for the hyperarousal/re-experiencing,  numbing,
and  avoidance  subscores  (Costa-Requena  &  Gil, 2010).
PTG.  The  Posttraumatic  Growth  Inventory  (PTGI;
Tedeschi  &  Calhoun,  1996)  focuses  on  the  assessment  of pos-
itive  changes  experienced  after trauma.  The  21-item  PTGI
yields  a  total  score  and  five  subscale  scores,  as  follows:
new  possibilities  (5  items),  relating  to  others  (7  items),  per-
sonal  strengths  (4  items),  appreciation  of life  (3 items),  and
spirituality  (2  items).  Items  are  rated  on  a  6-point  Likert
scales,  ranging  from  0  (did  not  experience  this change)  to  5
(experienced  this  change  strongly).  In  this  study,  the  Span-
ish  version  of  PTGI  was  used,  showing  good  reliability  index
(.91)  in  our  sample,  similar  to  the one  obtained  by Costa-
Requena  and  Gil  (2010)  of .95.  To  assess  the authenticity
of  PTG  facilitation  we  evaluated  two  interpersonal  indica-
tors:  ‘‘corroborated  PTG’’  and ‘‘vicarious  PTG’’  in  relatives.
A  modified  version  of  the PTGI  was  therefore  also  given  to
significant  others  (86.7%  couples,  6.7%  brothers,  6.7%  sons)
to  enquiry  about  their  perception  of  PTG in  patients  (i.e.,
corroborated  PTG).  Significant  others  were  also  asked  about
their  own  PTG due  to  the cancer  diagnosis  of  their  loved  one
(i.e.,  vicarious  PTG).  The  instructions  were  modified  to  ask
significant  others  about  their  own  PTG and their  opinion  of
patient’s  PTG.  To  ensure  that dyads  did not discuss  PTGI,
a  pre-paid  sealed  envelope  was  sent  to  significant  others.
Patients  completed  the questionnaires  in the hospital.  In
both  cases,  the instructions  explicitly  asked  informants  to
fill  in  questionnaire  individually  without  discussing  it  with
their  dyads.
Extreme  Life Events.  The  Extreme  Life  Events  Inven-
tory  (Pérez-Sales  et al.,  2012) collects  information  about
the  number  and  the impact  (threat  and  influence  on  one’s
lifetime  trajectory)  of 34  extreme  life  experiences,  mostly
related  to  trauma,  loss,  and  crisis.  Prior  to  the  cancer  expe-
rience,  participants  could  have  had  other  extreme  vital
experiences,  which  could  affect  the  PTG  reports  before  PPC
treatment.  In this study,  the number  of  prior  extreme  events
that  decisively  influenced  the life  trajectory  was  used to
control  for  the  effects  of PTG facilitation  on  stress  reduction
in  the  PPC  (M  = 1.32;  SD  =  1.29).
Intervention
PPC  aimed  to  facilitate  PTG  through  psychotherapeutic
methods  that  have been  associated  with  the development
of  positive  life  changes  after  cancer  (see  Table  1).  The
program  consisted  of  12  weekly  sessions  of  90--120  minutes
in  length.  Each  group  comprised  8--12  patients  confirmed
as  being  disease-free  after completing  their  primary  can-
cer  treatment.  Sessions  were  spread  across  four modules,
each  of  which  had different  lengths  and  aims  (see  Table  1).
The  general  objective  for  the first  two  modules  was  the
assimilation  of  the cancer  experience,  while  the final  two
modules  focused  on encouraging  accommodation  and  per-
sonal  transformation  (growth)  from  the illness  experience.
The  manualized  program  and  guide  is  available  in  Spanish
(Ochoa  et  al.,  2010)  and  English  (Ochoa  &  Casellas-Grau,
2015).
Procedure
Consecutive  participants  based on  time  of recruitment  were
allocated  to the PPC or  waiting-list  control  group  depend-
ing  on  the  availability  of  the  PPC  intervention.  When  PPC
was  not  available  in the short  term  (more  than  two  weeks),
participants  were  allocated  to  a waiting  list  group  for  three
months  (the  same  period  as  the active  PPC  treatment).  After
that, for  ethical  reasons,  they  were  assigned  to  receive  usual
psycho-oncological  individual  attention  (treatment  as  usual,
TAU)  without  waiting  for  the 12-month  follow-up  in  the PPC
group  to  finish.  Therefore,  the waiting-list  group  assess-
ments  were  not  included  as  part  of the  intervention  group
and  the 3- and  12  month  time-points  were  only  assessed
for  the  patients  who  participated  in  the  PPC  group.  TAU
in  psycho-oncology  departments  generally  comprises  non-
systematic  individual  sessions  focused  in emotional  support
and psychoeducation.  The  four  clinical  psychologists  who
conducted  the therapy were  supervised  by  two  experts  in
the application  of  PPC  to  assess  its  fidelity  to  the man-
ual  (Ochoa  et  al.,  2010). Treatment  integrity  (or  fidelity)
was  assessed  directly  by  these two  supervisors  via moni-
tors  or  via  videotaping  randomly  and  without  notifying  the
therapist,  in 25%  of  the  group  intervention  sessions.  We
also  assessed  integrity  by  measuring  therapist  adherence
as well  as  competence  in an ad-hoc  questionnaire  adapted
and  summarized  from  the  Cognitive  Therapy  Scale  Revised
(Blackburn  et  al.,  2001).  The  ad-hoc  questionnaire  assessed:
agenda  (sequence  of  the 4 modules  and  their  tasks),  concep-
tual  integration,  appropriate  positive  feedback,  application
of  positive  change  methods  and  homework  tasks.  The  two
supervisors  scored  the same  groups  independently.  We  cal-
culated  interrater  supervisor’s  agreement  using  the T index,
which  allows  the evaluation  of rater  agreement  along  ordi-
nal  scales.  Agreement  was  defined  as  identical  scores  on
an  item  on  a 4-point  scale.  The  overall  T  index  was  .89
(Perepletchikova,  Treat  &  Kazdkin,  2007).
Statistical  analysis
Statistical  analysis  was  performed  using  IBM  SPSS  for
Windows,  Version  21.0  (IBM  Corp.,  Armonk,  NY,  USA).  Dif-
ferences  between  participants  and  non-participants  were
examined  by  Student  t  tests  and 2.  Multivariate  analyses
of  variance  involving  repeated  measures  were  performed  on
an  intention  to  treat  analysis  (ITT) basis  to analyze  changes
of  the intervention  over  time.  Therefore,  analysis  of vari-
ance  were  performed  to  study  the  psychological  changes
between  groups  at T0  and  T1  as  well  as  the  stability  of  the
effects  of  the  PPC  at follow-up,  and the  reported  effect  size
is  partial  2.  To  examine  the corroboration  of  PTG,  intra-
class  correlation  and  simple  linear  regression  were  used,  as
appropriate  reporting,  respectively,  ICC  and lineal  regres-
sion  coefficients  (B),  as  well  as  95%  confidence  intervals.  In
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Table  1  Positive  Psychotherapy  for  cancer  description.
INITIAL  PHASES:  FAVORING  ASSIMILATION  PROCESSESS
Module  Session  Aim  Therapeutic  elements  in each  session
1  1-2  a.  Promoting
attitudes  to  facilitate
growth  from  disease.
b. Favoring  emotional
expression  and
processing.
1.  ‘‘What  did  the diagnosis  of  cancer  mean  for
me?’’ Promoting  vital  curiosity,  group  universality
and  change  openness.
2.  Working  with  positive  and negative  emotions:
somatic  consciousness,  symbolization  and
adaptive  emotional  reframing.
2 3-5  Emotional  regulation
and  coping
3.  Coping  styles  and  emotional  regulations:
consciousness  and  emotional  assessment.
4.  Horizons  of  positive  change  and healthy  life
style.
5.  Personal  strengths  and  memories  of  success  in
coping with  past  adverse  events.
INTERMISSION  AND  FINAL  PHASES:  FAVORING  ACCOMODATION  PROCESSES
3  6-9  PTG  facilitation  6.  Giving  meaning  to  the  experience.  Work  with
recent  and  remote  positive  memoirs.
7. Giving  meaning  to  the  experience.  Personal
realization  guidelines  and  hope-based
interventions
8. Relational  growth:  Promoting  and  awaking
interest  towards  significant  others  and  working
with  positive  models  against  adversity
9. Relational  growth:  Gratitude  and
forgiveness-based  interventions.
4 10-12  a.  Existential  and
spiritual  aspects
b.  Group  conclusion
10.  Foreseeing  recurrence,  increase  of  mortality
and transience  consciousness,  and  dealing  with
emotional  anesthesia
11.  Transcendence  and  regret  as a  constructive
way
12. Farewell  letter  and  review  of  the  group
experience
addition,  to  analyze  intrapersonal  variables  of  PTG  corrob-
oration,  simple  regression  analysis  was  performed.  Finally,
predictive  analysis  was  performed  to  assess  the  role  of  PTG
facilitation  in  reducing  posttraumatic  stress  symptoms  after
PPC,  reporting  linear  regression  coefficients  (B)  and  95%
confidence  intervals.  Statistical  significance  was  assumed  at
a  p <.05.
Results
Study  group
Figure  1  shows  a flowchart  of the  numbers of participants
recruited  and  allocated  to  each group,  followed-up,  and
analyzed.  Of  the 158  patients  recruited,  28  refused  to  par-
ticipate  because  of  health  issues  (n  = 6),  lack  of time  (n  =
9),  and  lack  of  interest  (n =  13).  In addition,  four  women  did
not  meet  the inclusion  criteria.  The  remaining  126  subjects
were  then  allocated  to  either the control  group  (n = 53)  or
the  PPC  group  (n = 73).
Sample  characteristics
Sociodemographic  and  medical  characteristics  are  pre-
sented  in Table 2  for  both  treatment  and  control  groups.  No
significant  differences  were  found  between  groups  at base-
line  (T0),  specifically  in the  PCL,  HADS,  and  PTGI.  There
were  no  significant  differences  between  those  who  declined
to  participate  and  those  in the  control  group.
Differences  in  psychological  changes  between
groups at  T0 and T1
A two-way  mixed  multivariate  analysis  of  variance  was
performed  on  an ITT  basis.  Missing  responses  from  9  (14.2%)
participants  in PPC  group  and  10  (18.8%)  participants  in
WL  group  were  imputed  as  the last  observation  carried
forward.  Results  revealed  a  statistically  significant  inter-
action  between  group  (PPC vs  waiting  list) and  time  (T0  vs
T1),  F(5,83)  = 5.44,  p <.001,  partial  2 =  .25.  Specifically,
compared  to  the  waiting  list  group,  the strongest  reduction
of  PCL and  HADS  scores  in the  PPC  group indicate  less
negative  mood  and  stress  in T1  among  those  participants
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Assessed for eligibility ( n=158)
Excluded ( n=3 2)
- No t meeti ng inclusion  crit eria 
(n=4)
- Declined to part icipate (n=28)
Analyzed (n=5 4)
- Excluded from the analysis ( n=0)
Lost to follow-up (n=19)
- Not able to contact with ( n=5)
- Did no t finall y respond o ne of the 
three and 12 follow-up que stionn aires 
(n=1 4)
Allocated to the intervention ( n=73)
- Received allocated intervention ( n=63)
- Did not receive allocated interven tion 
(n= 10)
All ocated  to the wa iti ng list (n=5 3)
- Completed  the w aiting li st pe riod 
(n=4 3)
- Did no t complete  the wa iting li st 
period  (n=1 0)
Alloc ation
Analy sis
Follow-Up
Allocated (n=12 6)
Enro llment
Figure  1  CONSORT  figure  of  participants’  allocation.
receiving  PPC compared  to  those  in  the  waiting  list. The
effect  size  value  of  the partial  2,  suggest  that the  PPC
program  contributes  remarkably  to  a  positive  psychological
functioning.  On the  other  hand,  although  PPC group  showed
greater  increases  than  the  WL  group  in PTGI  pre-post  scores,
no  statistically  significant  interactions  were  detected  in any
of  its subscales.
In  much  the same  way,  univariate  tests  also  indicated
statistically  significant  interactions  between  group  and time
on  every  PCL  subscale  (Intrusions,  F(1,87)  =  8.16,  p  =.005,
partial  2 =  .09;  Avoidance,  F(1,87)  = 11.46,  p  =.001,  partial

2 =  .12;  Hyperarousal,  F(1,87)  = 17.78,  p <.001,  partial 2
= .17)  and  every  HADS  subscale  (Anxiety,  F(1,87)  =  11.49,  p
=.001,  partial  2 = .12; Depression,  F(1,87)  = 12.07,  p  =.001,
partial  2 =  .12).
Stability of the effects  of the PPC  at  follow-up
In order  to  study  the  evolution  of the positive  functioning  in
those  participants  allocated  to  PPC  program,  multivariate
repeated  measures  analysis  of  variance  of the  total  PCL,
HADS  and  PTGI  scores  was  performed  on  an ITT  basis.  Miss-
ing  responses  from  9  (14.2%)  participants  in PPC  group
and  10  (18.8%)  were  imputed  as  the last  observation  car-
ried  forward.  The  observed  multivariate  F test  value  was
statistically  significant,  F(9,62)  =  10.49,  p  <.001,  partial

2 =.60. The  univariate  tests  showed  a  significant  varia-
tion  over time  of the  scores  of  PCL,  F(3,210)  = 38.04,  p
<.001,  partial  2 =.35;  HADS,  F(3,210) =  17.92,  p  <.001,
partial  2 =.20;  and PTGI,  F(3,210) =  6.31,  p  =.001,  par-
tial  2 =.08  in  line  with  the expected  contribution  to  the
positive  psychological  functioning,  that  is,  PCL  and  HADS
scores  decreasing  over  time,  and  PTGI  scores  increasing  (see
Figure  2).
Contrasts  showed  a statistically  significant  lineal  com-
ponent  for  PCL,  F(1,70)  = 62.47,  p <.001,  HADS,  F(1,70)  =
44.21,  p  <.001,  and  PTGI,  F(1,70)  = 9.56,  p  =.003.  Interest-
ingly,  a  quadratic  component  was  also  significant  for  PCL,
F(1,70)  =  28.39,  p <.001,  for HADS,  F(1,70)  =  4.61,  p =.036,
and  for PTGI,  F(1,70)  = 3.95,  p  =  .050,  which  according  to
Figure  2 suggest a major change  from  pre-intervention  (T0)
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Table  2  Comparison  of  samples’  sociodemographical  and  medical  characteristics  between  PPT  and  WLG  groups.
PPT group
n=73
WLG  group
n=53
p
Age (years) .812
Mean  48.93  48.49
SD  9.486  11.907
Min-Max  31-70  20-70
Mean  time  since  diagnosis (months)
Mean  17.36  19.08  .523
SD  12.71  17.03
Mean  time  since  treatment (months)
Mean  8.34 10.08  .523
SD  9.92 17.11
PPT  group  %
n=73
WLG  group  %
n=53
p
Marital  status .220
Married/partnered  75.3  86.8
Separated/divorced  15.2  3.8
Never  married  6.8  7.5
Widowed 2.7  1.9
Educational  level .615
High school or  less  53.4  48.1
Some  college  30.2  38.5
University  studies  16.4  13.4
Working  status  .783
Employed  11.0  13.2
Unemployed  89.0  86.8
Children  .977
Yes  79.5  79.2
No  20.5  20.8
Cancer  site  .340
Breast  83.6  96.2
Uterine  corpus  4.1  .00
Hodgkins  lymphoma  1.4  1.9
Non-hodgkins  lymphoma 1.4 1.9
Colon  2.7  .00
Myelogeneous  leukemia 2.7  .00
Ovary/Fallopian  tube  2.7  .00
Rectum  1.4  .00
Psychotropic  medication .872
None  53.4  64.2
Anxiolytic  26.0  7.5
Antidepressant  5.5  11.3
Anxiolytic  +  Antidepressant  11.0  13.2
Hypnotic  4.1  3.8
Cancer  stage  .731
0  2.9  .00
I  40.6  45.3
II  34.8  30.2
III  17.4  18.8
IV  4.3  5.7
Cancer  surgery .520
Yes  89.0  92.5
No  11.0  7.5
Cancer  treatment
Chemotherapy 79.5  79.2  .977
Radiotherapy  72.6  84.9  .101
Note. Between-groups characteristics were compared using chi square-based tests, except for age, time since diagnosis, and treatment
differences which were analyzed using t-tests.
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PTGIHADS
T0 T1 T2 T3
n=63 n=63 n=54 n=54
d=–10.03 d=–1.86     d=–0.3
T0 T1 T2 T3
n=63 n=63 n=54 n=54
d=–3.8         d=–0.53         d=–0.91
T0 T1 T2 T3
n=63 n=63 n=54 n=54
d=6.55          d=–.87         d=1.42
PCL-C
1
42.5
45.0
47.5
50.0
52.5
55.0
22
58
56
54
52
21
20
19
18
17
16
 2 3 4 1 2 3 4 1 2 3 4
Figure  2  Psychological  outcomes  along  assessments:  pre-intervention  (T0),  post-intervention  (T1),  3 months  follow-up  (T2),
and 12  months  follow-up  (T3).  d= between-stage  differences.  PCL-C:  posttraumatic  stress;  HADS:  mood;  PTGI:  positivechanges
experienced  after  trauma.
to post-intervention  (T1),  and  a  stabilization  of  the scores
on  the  follow-up  (T1  to T3).
Authenticity  of PTG facilitation
Results  from  the  intraclass  correlation  (ICC)  index indicated
agreement  between  patient’s  and  caregiver’s  PTGI  results
(ICC  = .663;  95%  CI  =  .481--.782;  p  <.001),  corroborating  that
PTG  occurred  in the  patient.  After  the PPC  program,  the ICC
even  increased  slightly  (ICC  =  .712;  95%  CI  = .459--.846;  p
<.001).  Linear  regression  showed  that  before  the PPC  pro-
gram,  there  was  a significant  relationship  between  the  PTGI
scores  of  significant  others  and patients  (B  = .33;  p  =  .042;
95%  CI  =  .12--.65).  However,  the relationship  became  statis-
tically  not  significant  (B = .28;  p = .115;  95%  CI  =  --.07--.64)
after  completing  the  PPC  program,  with  patients  reporting
higher  PTGI  scores  than  significant  others. Therefore,  the
influence  of a patient’s  PTG on  their partners’  PTG  was  only
significant  before  the PPC  program.
Predictive  role  of PTG  facilitation on
post-traumatic stress reduction after PPC
PTG facilitation  was  calculated  using  the  increase  of  PTGI
(pre-post  PPC treatment).  The  predictive  role of  PTG  facil-
itation  on stress  reduction  after  the  PPC  was  explored
through  a  linear  regression  predictive  analysis,  which
resulted  in  .25  (95%  CI  =  .10--.41;  p = .052)  when  control-
ling  for  the  number  of prior  extreme  threatening  life  events
reported  by  each individual.
Discussion
A high  rate  (50%--90%)  of  those  who  have  experienced  onco-
logical  disease  report  positive  life  changes  (e.g.  PTG),  even
without  psychological  intervention  (Sawyer  et  al.,  2010;
Sumalla  et  al.,  2009). Although  these  positive  life  changes
are  associated  with  better  adjustment  to  disease  (Helgeson
et  al.,  2006;  Morrill  et  al.,  2006;  Sawyer  et  al.,  2010),
the  power  of psychological  treatment  to  facilitate  PTG
and  increase  the  potential  better  adjustment  to  illness  by
reducing  emotional  distress  or  posttraumatic  stress  (Roepke,
2014)  is  poorly  understood.  Cognitive-behavioral  stress  man-
agement  (Antoni, 2003) was  the  first  therapy  which has
shown  the potential  of  psychological  therapies  to  promote
growth  in  cancer  patients  measured  with  a cancer-specific
benefit-finding  inventory  (Antoni  et al.,  2006; Penedo  et  al.,
2006). However,  this therapy  was  designed  to  focus  on  and
target  stress  management,  which  only  increases  growth  as
a  side  effect.  In this  present  study,  our  primary  aim  was
therefore  to test  the hypothesis  whether  PPC,  that  was
specifically  designed  to  facilitate  PTG  in patients  with  can-
cer,  could  promote  stress  reduction.
Our  results  showed  that  PTG  could  be facilitated
by  the  PPC  program,  and  that  increases  in PTG  were
associated  with  decreases  in emotional  distress  and  post-
traumatic  stress.  PPC  group  compared  with  WL  group
showed  an increase  in  PTG from  pre-intervention  (T0) to
post-intervention  (T1),  that  was  maintained  at 3  and  12
months  of  follow-up,  but  this increase  was  not statistically
significant.  However,  PTG  facilitation  predicted  a  decrease
in  posttraumatic  stress  after  the PPC,  when  controlling  for
the  number  of  prior  extreme  threatening  vital  events.
With  regard  to  the  evolution  of  PCL  and  HADS  scores,
results  suggested  a  major change  from  pre-intervention  (T0)
to  post-intervention  (T1),  and a stabilization  of the  scores  on
the  follow-up  (T1  to  T3).  A  meta-analysis  (Helgeson  et  al.,
2006), clarified  the relationship  between  stress  and growth,
observing  that  high  levels  of  growth  and  emotional  distress
could  coexist  in the initial  phases  of  cancer,  but  that growth
was  associated  with  a decrease  in emotional  distress  in later
phases  of  survivorship.  After  acute  treatment,  it seems  that
PTG  results  from  an  accommodation  to  the  oncological  expe-
rience,  and  that  this  has  a  therapeutic  value  through  the
associated  stress  reduction,  as  show  our  results.
Those  psychological  therapies  that  focus  on  stress  man-
agement  have  shown  the greatest  therapeutic  impact  on
distressed  patients  who  are  immersed  in  coping  with  the
initial  cancer  stressors  of  diagnosis  and  treatment  (Antoni,
2003;  Penedo  et  al.,  2006).  However,  our  results  suggest
that  facilitating  PTG through  the PPC  program  could  be suit-
able  for  stress  reduction  in patients  who  show  high  levels  of
Documento descargado de http://www.elsevier.es el 02-02-2017
36  C. Ochoa  et al.
stress  or distress  after  completing  oncological  treatment.
The  facilitation  of  PTG in these  situations  could  serve  as  a
way  of  providing  meaning,  of  processing  distress,  and  trying
to  accommodate  prior  views  to  disturbing  disease-related
questioning.  Reliably,  psychological  treatments  in cancer
may  need to  be  time-oriented.  In  the  initial phases,  dur-
ing  diagnose  and  primary  oncological  treatments,  could  be
suitable  stress  management  therapies  more  focused  in man-
aging  the threat  of  initial  stressors  (surgical  intervention,
chemotherapy  and  radiotherapy).  After  primary  oncological
treatments,  it  could  be  more  suitable  a PTG  facilitation  ther-
apy,  where  patients  begins  to  accommodate  the experience
and  are  open  to consider  vital  changes.  In fact,  there  is  an
association  between  high  levels  of  posttraumatic  stress  and
loss  of  quality  of  life  in cancer  survivor  patients  (Haberkorn
et  al.,  2013),  which  could  be  buffered  by  PTG  (Morrill  et  al.,
2006)  after  oncological  treatments.
We  also  aimed  to  assess  the  authenticity  of PTG  induced
by  the  PPC  program.  We  found  that PTG  in patients  was  cor-
roborated  by  their  significant  others  before  and  after  PPC,
with  pre-treatment  correlations  similar  to  those  obtained  in
comparable  studies  (Moore  et  al.,  2011;  Shakespeare-Finch
& Barrington,  2012).  However,  this  is  probably  the first  study
in  which  significant  others  also  corroborated  the induced
PTG  after  psychological  treatment,  thereby  strengthening
the  correlation  between  self-reported  and  corroborated  PTG
and  providing  relational  authenticity  to  the  results.
On  the  other  hand,  when comparing  PTG  between
patients  and  significant  others  seems  that  the  increase  in
PTG  observed  among  cancer  patients  after  the  PPC  pro-
gram  does  not  explain  the  changes  in  PTG  among  significant
others,  even  when  significant  others  could  perceive  and
corroborate  the  patients’  PTG.  These  results  can  be  under-
stood  given  the  lack  of psychological  treatment  offered  to
significant  others.  As  some  studies  show,  the  PTG induced
during  cancer  diagnosis  and  treatment  can  generate  positive
change  and  PTG  in  significant  others.  However,  this prob-
ably  only  occurs  through  vicarious  growth,  when  they  get
involved  in  the  initial  emotional  impact  and  the  patient’s
needs  (Ochoa  et  al.,  2013);  this  would  be  more  difficult
during  survivorship  where  we  run  PPC. Indeed,  many  sur-
vivors  have  commented  on this  lack  of attention,  empathy,
and  harmony  after  oncological  treatment:  ‘‘they  (significant
others)  believe  that  everything  is  fine  now  (after  treatment),
but  I do  not  feel  like  that’’  (Ochoa  et al.,  2010).  Therefore,
when  significant  others  do  not  receive  any  psychological
treatment  and  do not  perceive  the  ongoing  threat  that
remains  in  cancer  survivors,  vicarious  growth  could  be pre-
vented  from  emerging  in them  after  the  PPC.  This  hypothesis
that  significant  others  need  to  participate  in psychological
treatment  to  facilitate  PTG was  reinforced  in a recent  study
(Heinrichs  et al.,  2011), in which  the authors  used couples,
group-based  psychological  treatment  for  cancer  survivors
and  their  partners.  They  showed  that  PTG increased  in both
partners  and  cancer  survivors  after  treatment.
The  findings  from  the current  study  should  be  evaluated
in  the  context  of  the  study’s  methodological  limitations.
First,  the  control  group  was  not  ideal  because,  besides  the
ethical  problem  of waiting  for  treatment,  the  expectation
of  waiting  could  have  influenced  the  results.  Moreover,  the
waiting-list  group  only  went three  months  without  follow-
up  and  it  would  have been  preferable  compared  PPC  with
traditional  active  treatments  with  empirical  support.  The
main  limitation  of  this  study is  the  absence  of  a random-
ized  assignation  of  participants  to  study  conditions.  So,
although  PPC appears  to promote  long  term  PTG,  its  efficacy
requires  validation  with  a randomized  control  group  with
longer  follow-ups.  Finally,  as  it happens  in multicomponent
psychological  treatment  programs,  in our  study  it is  not  pos-
sible  to  discern  which  elements  of the  program  are  those
with  greater  or  less psychotherapeutic  impact.
In  summary,  this  study  has  shown  the positive  effects  of
facilitating  PTG  among  cancer  survivors  through  a  PPC  pro-
gram  compared  with  a control  group.  To  our  knowledge,  this
is  the  first  study  to  show  that  a  treatment  focused  on  PTG
could  achieve  significant  and  maintained  reductions  in both
posttraumatic  stress  and  emotional  distress.  The  facilitation
of  PTG seems  to  be optimal  in  reducing  distress  and stress
reactions  over time  in cancer  survivors.  This  facilitation  is
corroborated  by  significant  others.
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